𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis and Anti-Hepatitis B Virus Activity of a Novel Class of Thiazolylbenzimidazole Derivatives

✍ Scribed by Yu Luo; Jia-Ping Yao; Li Yang; Chun-Lan Feng; Wei Tang; Gui-Feng Wang; Jian-Pin Zuo; Wei Lu


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
150 KB
Volume
344
Category
Article
ISSN
0365-6233

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recently, heterocyclic benzimidazole derivatives have been investigated and validated as a promising class of antiviral agents. In this paper, a series of novel thiazolylbenzimidazole derivatives was synthesized and evaluated for their anti‐hepatitis B virus (HBV) activity and cytotoxicity on the HepG2.2.15 cell line. Afterwards, the preliminary structure–activity relationship (SAR) was discussed. Compound 8b, with IC~50~ = 1.1 ¡M and SI > 90.9, was the most promising compound and could be selected as a benchmark compound for further investigation.


πŸ“œ SIMILAR VOLUMES


Synthesis and pharmacological evaluation
✍ Angeliki P. Kourounakis; Dimitrios Galanakis; Karyofillis Tsiakitzis; Eleni A. R πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 1 views

The role of reactive oxygen species in inflammatory processes has been well documented, while several antioxidant compounds have been shown to exhibit anti-inflammatory activity. We designed novel compounds as potential agents that combine enhanced antioxidant and anti-inflammatory activities. Deriv

A novel deletion mutant of hepatitis B v
✍ Weinberger, Klaus M.; Zoulek, Gert; Bauer, Tanja; BοΏ½hm, Stephan; Jilg, Wolfgang πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 1 views

HBsAg is the most important serological marker for acute or chronic hepatitis B. Nevertheless, there are reports of HBsAg-negative virus carriers, either with anti-HBc as the only marker for hepatitis B virus (HBV) infection or even positive for anti-HBs and anti-HBc. We report isolates from a patie